These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 8840099
1. Role of albumin glycation on the erythrocyte aggregation: an in vitro study. Candiloros H, Muller S, Ziegler O, Donner M, Drouin P. Diabet Med; 1996 Jul; 13(7):646-50. PubMed ID: 8840099 [Abstract] [Full Text] [Related]
2. Structural modifications of human albumin in diabetes. Guerin-Dubourg A, Catan A, Bourdon E, Rondeau P. Diabetes Metab; 2012 Apr; 38(2):171-8. PubMed ID: 22349032 [Abstract] [Full Text] [Related]
3. The association of advanced glycation end-products with glutathione status. Sahin E, Göçmen AY, Koçak H, Tuncer M, Gümüslü S. Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621 [Abstract] [Full Text] [Related]
4. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. Zoellner H, Hou JY, Hochgrebe T, Poljak A, Duncan MW, Golding J, Henderson T, Lynch G. Biochem Biophys Res Commun; 2001 Jun 01; 284(1):83-9. PubMed ID: 11374874 [Abstract] [Full Text] [Related]
9. A novel advanced glycation index and its association with diabetes and microangiopathy. Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V. Metabolism; 2005 Aug 01; 54(8):1002-7. PubMed ID: 16092048 [Abstract] [Full Text] [Related]
10. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Schmitt A, Schmitt J, Münch G, Gasic-Milencovic J. Anal Biochem; 2005 Mar 15; 338(2):201-15. PubMed ID: 15745740 [Abstract] [Full Text] [Related]
11. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management. Rajasekar P, Anuradha CV. Acta Diabetol; 2007 Jun 15; 44(2):83-90. PubMed ID: 17530472 [Abstract] [Full Text] [Related]
14. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Gerdemann A, Lemke HD, Nothdurft A, Heidland A, Münch G, Bahner U, Schinzel R. Clin Nephrol; 2000 Oct 15; 54(4):276-83. PubMed ID: 11076103 [Abstract] [Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs). Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Inoue H. Diabetes Metab Res Rev; 2009 Mar 15; 25(3):266-71. PubMed ID: 19165765 [Abstract] [Full Text] [Related]
16. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Lapolla A, Fedele D, Seraglia R, Traldi P. Mass Spectrom Rev; 2006 Mar 15; 25(5):775-97. PubMed ID: 16625652 [Abstract] [Full Text] [Related]
17. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea. Lunceford N, Gugliucci A. Fitoterapia; 2005 Jul 15; 76(5):419-27. PubMed ID: 15894431 [Abstract] [Full Text] [Related]
18. The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate. Rohovec J, Maschmeyer T, Aime S, Peters JA. Chemistry; 2003 May 23; 9(10):2193-9. PubMed ID: 12772293 [Abstract] [Full Text] [Related]
19. Red blood cell aggregation in diabetes mellitus. Le Devehat C, Vimeux M, Bondoux G, Khodabandehlou T. Int Angiol; 1990 May 23; 9(1):11-5. PubMed ID: 2212794 [Abstract] [Full Text] [Related]
20. Alginate as an antiglycating agent for human serum albumin. Sattarahmady N, Khodagholi F, Moosavi-Movahedi AA, Heli H, Hakimelahi GH. Int J Biol Macromol; 2007 Jul 01; 41(2):180-4. PubMed ID: 17350677 [Abstract] [Full Text] [Related] Page: [Next] [New Search]